Longitudinal Undetectable Molecular Residual Disease Defines Potentially Cured Population in Localized Non–Small Cell Lung Cancer

The efficacy and potential limitations of molecular residual disease (MRD) detection urgently need to be fully elucidated in a larger population of non–small cell lung cancer (NSCLC). We enrolled 261 patients with stages I to III NSCLC who underwent definitive surgery, and 913 peripheral blood sampl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jia-Tao, Liu, Si-Yang, Gao, Wei, Liu, Si-Yang Maggie, Yan, Hong-Hong, Ji, Liyan, Chen, Yu, Gong, Yuhua, Lu, Hong-Lian, Lin, Jun-Tao, Yin, Kai, Jiang, Ben-Yuan, Nie, Qiang, Liao, Ri-Qiang, Dong, Song, Guan, Yanfang, Dai, Pingping, Zhang, Xu-Chao, Yang, Jin-Ji, Tu, Hai-Yan, Xia, Xuefeng, Yi, Xin, Zhou, Qing, Zhong, Wen-Zhao, Yang, Xue-Ning, Wu, Yi-Long
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394392/
https://www.ncbi.nlm.nih.gov/pubmed/35543554
http://dx.doi.org/10.1158/2159-8290.CD-21-1486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9394392/
https://www.ncbi.nlm.nih.gov/pubmed/35543554
http://dx.doi.org/10.1158/2159-8290.CD-21-1486

Ejemplares similares